These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Determinants of compliance with anticoagulation: A case-control study. Arnsten JH; Gelfand JM; Singer DE Am J Med; 1997 Jul; 103(1):11-7. PubMed ID: 9236480 [TBL] [Abstract][Full Text] [Related]
23. Warfarin resistance and vitamin K. Lee M; Schwartz RN; Sharifi R Ann Intern Med; 1981 Jan; 94(1):140-1. PubMed ID: 7447217 [No Abstract] [Full Text] [Related]
24. Investigation of patients with abnormal response to warfarin. Bentley DP; Backhouse G; Hutchings A; Haddon RL; Spragg B; Routledge PA Br J Clin Pharmacol; 1986 Jul; 22(1):37-41. PubMed ID: 3741725 [TBL] [Abstract][Full Text] [Related]
25. Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect. Rudnicka AR; Ashby D; Brennan P; Meade T Arch Intern Med; 2003 Jun; 163(12):1454-60. PubMed ID: 12824095 [TBL] [Abstract][Full Text] [Related]
26. Effect of warfarin nonadherence on control of the International Normalized Ratio. Waterman AD; Milligan PE; Bayer L; Banet GA; Gatchel SK; Gage BF Am J Health Syst Pharm; 2004 Jun; 61(12):1258-64. PubMed ID: 15259756 [TBL] [Abstract][Full Text] [Related]
27. Barriers to the use of warfarin: potential solutions. McAnulty JH J Interv Card Electrophysiol; 2004; 10 Suppl 1():17-20. PubMed ID: 14739735 [No Abstract] [Full Text] [Related]
28. An algorithm for managing warfarin resistance. Osinbowale O; Al Malki M; Schade A; Bartholomew JR Cleve Clin J Med; 2009 Dec; 76(12):724-30. PubMed ID: 19952297 [TBL] [Abstract][Full Text] [Related]
29. Warfarin resistance in a patient with short-bowel syndrome. Nutr Rev; 1987 Jul; 45(7):208-11. PubMed ID: 3614776 [No Abstract] [Full Text] [Related]
30. Warfarin resistance in a patient with short bowel syndrome. Brophy DF; Ford SL; Crouch MA Pharmacotherapy; 1998; 18(3):646-9. PubMed ID: 9620117 [TBL] [Abstract][Full Text] [Related]
31. Warfarin resistance associated with parenteral nutrition. Cheung LK; Agi R; Hyman DJ Am J Med Sci; 2012 Mar; 343(3):255-8. PubMed ID: 22143126 [TBL] [Abstract][Full Text] [Related]
33. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation. Burkiewicz JS Pharmacotherapy; 2005 Aug; 25(8):1062-7. PubMed ID: 16207096 [TBL] [Abstract][Full Text] [Related]
34. The prevalence of nontherapeutic and dangerous international normalized ratios among patients receiving warfarin in the emergency department. Newman DH; Zhitomirsky I Ann Emerg Med; 2006 Aug; 48(2):182-9, 189.e1. PubMed ID: 16953531 [TBL] [Abstract][Full Text] [Related]
35. Adherence with health regimens of patients on warfarin therapy. Kääriäinen M; Paukama M; Kyngäs H J Clin Nurs; 2013 Jan; 22(1-2):89-96. PubMed ID: 22784012 [TBL] [Abstract][Full Text] [Related]
36. Use of direct observed therapy to confirm compliance in a warfarin clinic. Deen R J Patient Saf; 2011 Dec; 7(4):232-3. PubMed ID: 22064623 [TBL] [Abstract][Full Text] [Related]
37. Temporary resistance to heparin and warfarin in treatment of deep vein thrombosis. Viswanathan B J Kans Med Soc; 1980 Oct; 81(10):468-9. PubMed ID: 7229498 [No Abstract] [Full Text] [Related]
38. Low-dose phenobarbitone as an indicator of compliance with drug therapy. Feely M; Cooke J; Price D; Singleton S; Mehta A; Bradford L; Calvert R Br J Clin Pharmacol; 1987 Jul; 24(1):77-83. PubMed ID: 3113467 [TBL] [Abstract][Full Text] [Related]
39. Initial evaluation of low-dose phenobarbital as an indicator of compliance with antimalarial drug treatment. Karbwang J; Fungladda W; Pickard CE; Shires S; Hay A; Feely M Bull World Health Organ; 1998; 76 Suppl 1(Suppl 1):67-73. PubMed ID: 9763725 [TBL] [Abstract][Full Text] [Related]
40. Drug resistance, inappropriate dosing and non-compliance in hypertensive patients. Silas JH; Tucker GT; Smith AJ Br J Clin Pharmacol; 1980 Apr; 9(4):427-30. PubMed ID: 7378260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]